Knight Therapeutics Inc T.GUD

Exelon & HUGE GROWING UNMET NEED

[GoldenInvestor]

I'm excited to continue to learn more about the opportunities for Exelon,  

for Alzheimers and Dementia!

with an aging  population, the opportunities to help an ever increasing population is great!

a horrible disease, but it can be better managed with this product!  

& 26 countries to market it in! !!!

[MrMugsy]

Hey Golden ... just a quick calculation on the 26 countries involved. I used 2019 populations and I assumed the poverty line at 50% for all those countries (closer to 40 but let's stick with 50). For Canada, I used 30% as the poverty line. I divide the total population (above the poverty line) by Canada's population (above its poverty line) and we find that Knight's target market has

[GoldenInvestor]

Interesting when one breaks down the numbers & assess conservatively. at a population of 422.5 million, & Demetia affecting 5-8.5% (WHO), thinking all the people that can benefit from a GUD marketing team and strong distribution network. incredible opportunity for the people of South America & incredible for Knight!($$$) RECURRING! & this is just the first product across all our

[MrMugsy]

That's the key ... just the first product. Love to know if it opens the door to a bigger partnership with Novartis in the Americas (x-USA). Future acquirer of GUD by a company like Novartis?  Tell you in about 5-10 years.  Hahaha!

[Chianchin]

The market knows and is informed of the real facts and GUD potential a hell of a lot beter than these two financialy irrational promoting bozos. The ticker tell the real story. 22 yrs old Excelon will soon be replaced by new upcoming drugs. Just like selling old bold tires for canadian winter snow

[schocor]

While I disagree with your narrative, it is prudent to ask you what you believe to be a better investment in the healthcare/rnerspitkcs space. Thanks 

[Chianchin]

Always glad to help. Follow the following and if you sign up they will email you their BUY AND SELL day trade.  Currently I hold Surf, twist, CRSP, Repare. They do intensive research in the future disruptive biotech space. GUD HAD A GREAT CHANCE to get involved  but they waisted millions and seven Years  and no profits. The whole biotech industry has changed several times upside

[MrMugsy]

Chi-Chi's comments tell quite a tale. - he only visit's GUD on stockhouse yet says there are better investments and that he has other interests.  I bet he doesn't have any investments. - makes no attempt to engage anywhere else and really not trying to engage here. - only comes here to disrupt our attempts to hold coversations about GUD. All begging the question ... why ? I can&

[Chianchin]

Indeed keep an eye on ATE, and buy ATE the real potential and not GUD the side effect. 

[MrMugsy]

Haha ... Chi-Chi and friends only see the wall in front of them and don't see the garden on the other side.  Therefore the world must be a prison        : ) The further we go, the more GUD looks like PLB but at a bigger scale - with developments being much faster (from a revenue perspective). --------------------- Note:  updated GUD presentation for tomorrow

[porksniffer]

Market up 300 points, this turd? Nothing loolllll Where are all the 'value' investors taking positions on the 'good value'??? All silent, all gone missing. Doesn't feel too good. You could have put your money anywhere and come out way ahead. Enjoy your losses and dead money.  Remember folks, one of the worst performing companies in Canada the past 3-5 years. Market